end of life - Nursing Case Study
Pathophysiology
• Primary mechanism: Multi-organ failure - As the body approaches end of life, vital organs such as the heart, lungs, and kidneys progressively lose function due to decreased perfusion and oxygen delivery. This systemic decline results from cellular hypoxia and metabolic waste accumulation, leading to irreversible damage.
• Secondary mechanism: Dysregulated immune response - Chronic inflammation and immune system exhaustion occur as the body can no longer mount effective responses. This imbalance leads to increased susceptibility to infections and exacerbates organ failure.
• Key complication: Metabolic derangements - Imbalances in electrolytes and acid-base status arise due to impaired organ function, contributing to symptoms such as confusion, muscle weakness, and arrhythmias, further complicating the end-of-life process.
Patient Profile
Demographics:
76-year-old male, retired school teacher
History:
• Key past medical history: Chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), type 2 diabetes mellitus, and stage 4 chronic kidney disease
• Current medications: Lisinopril, metformin, furosemide, insulin glargine, albuterol inhaler as needed
• Allergies: Penicillin, sulfa drugs
Current Presentation:
• Chief complaint: Increasing shortness of breath and fatigue
• Key symptoms: Persistent cough, swelling in legs and abdomen, decreased appetite, confusion
• Vital signs: Blood pressure 98/60 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, oxygen saturation 88% on room air, temperature 37.2°C (99°F)
Section 1
During the initial assessment, the nurse notes a significant change in the patient's respiratory status. Despite being on supplemental oxygen via nasal cannula at 2 L/min, the patient's oxygen saturation remains low at 85%. His respiratory effort is visibly labored, with the use of accessory muscles and audible wheezing upon auscultation. The patient's cough is productive with thick, yellow sputum, suggesting a possible respiratory infection. The nurse also observes increased peripheral edema and ascites, indicating worsening heart failure and fluid overload. The patient's mental status has further declined, with periods of confusion and disorientation becoming more frequent.
Given these findings, the healthcare team orders a series of diagnostic tests to assess the patient's current condition. A chest X-ray reveals bilateral infiltrates consistent with pulmonary congestion and possible pneumonia. Blood tests show elevated white blood cell count, suggesting an infection, along with metabolic derangements such as hyperkalemia (potassium level of 5.8 mEq/L) and acidosis (blood pH of 7.32). Renal function tests indicate a further decline in kidney function, with a creatinine level of 3.8 mg/dL and blood urea nitrogen (BUN) of 50 mg/dL. These results confirm the complexity of the patient's condition, requiring careful coordination of treatments to address both the respiratory infection and the metabolic imbalances.
The healthcare team convenes to discuss the patient's declining status and potential interventions. They initiate broad-spectrum antibiotics to target the suspected pneumonia and adjust the diuretic regimen to manage fluid overload, taking care to monitor renal function closely. The patient's insulin therapy is modified to address potential fluctuations in blood glucose levels due to stress and infection. As the team considers the patient's goals of care and quality of life, discussions about palliative care options and advanced directives become more pertinent. This holistic approach aims to ensure that the patient receives compassionate care that aligns with his wishes during this critical phase of his illness.
Section 2
As the healthcare team implements the initial interventions, the patient's condition is closely monitored for any changes. Within the next 24 hours, the patient exhibits a partial response to the broad-spectrum antibiotics, evidenced by a slight decrease in the white blood cell count to 14,000/mm³, down from 17,000/mm³. However, the patient's respiratory status remains precarious. Despite the continued use of supplemental oxygen, his oxygen saturation fluctuates between 86% and 88%, and his respiratory rate remains elevated at 30 breaths per minute. A repeat chest X-ray shows persistent bilateral infiltrates, with no significant improvement in the pulmonary congestion.
Cardiac and renal functions continue to pose challenges. Despite the adjusted diuretic regimen, the peripheral edema and ascites show minimal reduction, indicating ongoing fluid retention. The patient's blood pressure is moderately low at 100/60 mmHg, raising concerns about perfusion and the balance between diuresis and hemodynamic stability. The metabolic panel shows persistent acidosis, with a blood pH of 7.30, and the hyperkalemia remains unresolved, with a potassium level of 5.9 mEq/L. The insulin adjustments have stabilized blood glucose levels around 140 mg/dL, but careful monitoring continues to be essential given the patient's labile metabolic state.
As the team evaluates this unfolding scenario, they recognize the need for further adjustments and potential escalation of care. A decision is made to introduce non-invasive positive pressure ventilation (NIPPV) to improve respiratory mechanics and oxygenation. Concurrently, nephrology is consulted to consider renal replacement therapy options given the worsening renal function. These measures reflect a strategic approach to managing the complex interplay of heart failure, infection, and renal impairment while remaining aligned with the patient's goals and advanced directives. The team remains vigilant, ready to adapt the care plan as the patient's response to these new interventions becomes apparent.
Section 3
In the following 24 hours, the healthcare team closely monitors the patient's response to the newly implemented non-invasive positive pressure ventilation (NIPPV). Initially, there is a modest improvement in respiratory parameters. The patient's oxygen saturation rises slightly, maintaining around 90-91%, and his respiratory rate decreases to 28 breaths per minute. Despite these positive changes, the patient reports increased fatigue and a sense of anxiety related to the mask, necessitating ongoing reassessment of his comfort and tolerance to the intervention.
Simultaneously, the nephrology team evaluates the patient's renal status. The latest metabolic panel indicates a worsening renal profile, with serum creatinine climbing to 3.2 mg/dL and blood urea nitrogen (BUN) at 58 mg/dL, indicating progressive renal impairment. The hyperkalemia persists with a potassium level of 6.1 mEq/L, despite conservative management with diuretics and dietary modifications. In light of these findings, nephrology recommends initiating renal replacement therapy via continuous renal replacement therapy (CRRT) to manage fluid overload and electrolyte imbalances, aiming to stabilize the patient's condition while avoiding further hemodynamic instability.
Although there have been some improvements in respiratory function, the patient develops new complications. The persistent acidosis, despite bicarbonate administration, now raises concerns for potential multi-organ dysfunction. The patient begins to exhibit signs of altered mental status, becoming slightly confused and disoriented, which prompts a neurological assessment to rule out any acute cerebral events or metabolic encephalopathy. The care team continues to prioritize communication with the patient's family, ensuring that the evolving care plan aligns with the patient's previously stated goals and advanced directives. As these new challenges unfold, the team remains committed to adapting their strategies to support the patient through this critical phase of his illness.
Section 4
The situation becomes more complex as the patient begins to exhibit new complications. Over the next few hours, the healthcare team notices a change in the patient's neurological status, highlighting the need for urgent assessment and intervention. His confusion and disorientation worsen, and he becomes increasingly lethargic. A focused neurological examination reveals that the patient is only intermittently oriented to person but not to place or time. Pupillary reactions remain intact, and there is no evidence of focal neurological deficits, suggesting that the altered mental state may be more related to metabolic disturbances rather than an acute cerebrovascular event.
Concurrent with these neurological changes, a repeat arterial blood gas (ABG) analysis reveals persistent metabolic acidosis with a pH of 7.28, bicarbonate of 17 mEq/L, and a PaCO2 of 40 mmHg. These results, in conjunction with the patient's rising serum creatinine and BUN, indicate that the acidosis is likely due to the worsening renal failure. The hyperkalemia remains resistant to previous interventions, now registering at 6.5 mEq/L, further contributing to the risk of cardiac arrhythmias and necessitating immediate attention.
In response to these developments, the healthcare team prioritizes the initiation of continuous renal replacement therapy (CRRT) to address the renal failure, manage the electrolyte imbalances, and hopefully improve the metabolic acidosis. The patient is started on CRRT, with careful monitoring of hemodynamic status to prevent any further instability. The team also administers calcium gluconate and insulin with glucose to transiently stabilize the elevated potassium levels. Throughout these interventions, the team maintains close communication with the patient's family, discussing the potential for further interventions while reaffirming the patient's goals of care. The next steps will focus on assessing the patient's response to CRRT and monitoring for any further complications that may arise.
Section 5
As the healthcare team closely monitors the patient following the initiation of continuous renal replacement therapy (CRRT), they note some initial positive changes in his clinical status. Over the next few hours, his serum potassium level begins to decrease, now measuring at 5.8 mEq/L, indicating a partial response to the interventions. However, despite this improvement, the patient's neurological status remains concerning. He continues to be lethargic and disoriented, and his orientation does not significantly improve. The team conducts a follow-up neurological assessment, noting that while his pupillary reactions remain brisk and equal, his Glasgow Coma Scale (GCS) score has slightly decreased to 10, emphasizing the need for ongoing vigilance.
In parallel, the patient's vital signs reveal new challenges. His blood pressure has decreased to 90/60 mmHg, and his heart rate has risen to 110 beats per minute, suggesting the onset of hemodynamic instability potentially linked to the CRRT initiation. The team suspects that the rapid fluid removal may be contributing to this hypotensive episode. To address these issues, they decide to adjust the CRRT settings to a slower fluid removal rate, while administering a cautious fluid bolus to support his blood pressure. The nursing staff is instructed to increase the frequency of vital signs monitoring and to be alert for any further signs of cardiovascular compromise.
Simultaneously, the team reviews the latest laboratory results, which show that while there is a slight improvement in the metabolic acidosis with a pH of 7.32 and bicarbonate of 19 mEq/L, the serum creatinine and BUN levels remain elevated, reflecting ongoing renal dysfunction. These findings prompt a multidisciplinary discussion to reevaluate the patient's overall prognosis and treatment goals. As the team communicates these developments to the family, they emphasize the importance of balancing aggressive interventions with the patient's previously expressed wishes, underscoring the need for a compassionate and patient-centered approach moving forward.